Skip to content

H.R. 8918 · 119th Congress (2025–2027)

BIO-SCALE Act

To provide for the establishment of technology maturation facilities for the bioindustrial sector, and for other purposes.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 8918’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. James R. Baird (R-IN-4)
Cosponsors
2 cosponsors

1 original · 1 later

  1. Rep. Chrissy Houlahan (D-PA-6)· Original · May 20, 2026
  2. Rep. Nikki Budzinski (D-IL-13)· Later · Oct 1, 2026
Policy area
Government Operations and Politics

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Transportation and Infrastructure, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseFinancial ServicesReferred May 20, 2026
  2. HouseTransportation and InfrastructureReferred May 20, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. BIO-SCALE Act

    Display title, Short title · Introduced in House

  2. Bioindustrial Infrastructure for Open Scale-up, Commercialization, and Accelerated Launch Ecosystems Act

    Short title · Introduced in House

  3. To provide for the establishment of technology maturation facilities for the bioindustrial sector, and for other purposes.

    Official title · Introduced in House